AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30132009 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive resistance training with elastic bands
Number of subjects: 59
Study 30132009 — intervention group
Group type: COMPARATOR
Intervention: General physical exercise
Number of subjects: 59
Study 28189551 — intervention group
Group type: EXPERIMENTAL
Intervention: Minor background vibratory stimulation to the trunk using a vibrating cushion
Number of subjects: 0
Study 28189551 — intervention group
Group type: EXPERIMENTAL
Intervention: Recorded sound vibrations
Number of subjects: 0
Study 28189551 — intervention group
Group type: COMPARATOR
Intervention: No extra sensory stimulation (Control group)
Number of subjects: 0
Study 26206832 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-Rich Plasma (PRP)
Number of subjects: 0
Study 26206832 — intervention group
Group type: COMPARATOR
Intervention: Whole Blood (WB)
Number of subjects: 0
Study 23350933 — intervention group
Group type: EXPERIMENTAL
Intervention: Pay-for-performance program (P4P) providing A$40 and A$100 for diabetes and asthma treatment, and A$35 for cervical cancer screening.
Number of subjects: 0
Study 21146687 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan
Number of subjects: 31
Study 21146687 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 31
Study 18773727 — intervention group
Group type: EXPERIMENTAL
Intervention: Training with mismatched locomotor and visual input
Number of subjects: 0
Study 18773727 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking to visual targets
Number of subjects: 0
Study 18773727 — intervention group
Group type: EXPERIMENTAL
Intervention: Locating visual targets in a spatial updating task
Number of subjects: 0
Study 17395029 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin-Glucose Infusion
Number of subjects: 0
Study 17395029 — intervention group
Group type: COMPARATOR
Intervention: Control (standard care)
Number of subjects: 0
Study 12701852 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with cancer
Number of subjects: 0
Study 12701852 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative care patients
Number of subjects: 0
Study 12701852 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (general practice attendees)
Number of subjects: 0
Study 11149435 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical ventilation with V(T) = 15 ml/kg ideal body weight on ZEEP
Number of subjects: 39
Study 11149435 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical ventilation with V(T) = 6 ml/kg ideal body weight on ZEEP
Number of subjects: 39
Study 11149435 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical ventilation with V(T) = 6 ml/kg ideal body weight on positive end‐expiratory pressure of 10 cm H2O
Number of subjects: 39
Study 8941007 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified type IV‐V radical hysterectomy with systematic pelvic and aortic lymphadenectomy
Number of subjects: 42
Study 1493837 — intervention group
Group type: EXPERIMENTAL
Intervention: Penicillin (Phenoxymethylpenicillin) 250 mg t.i.d. for adults and 125 mg t.i.d. for children
Number of subjects: 173
Study 1493837 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 173
Study 1493837 — intervention group
Group type: EXPERIMENTAL
Intervention: Penicillin
Number of subjects: 173
Study 30537874 — intervention group
Group type: EXPERIMENTAL
Intervention: Animal-assisted therapy as an adjunct to intensive family preservation services (n = 14)
Number of subjects: 28
Study 30537874 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 14)
Number of subjects: 28
Study 28027283 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV‐13 booster
Number of subjects: 178
Study 28027283 — intervention group
Group type: COMPARATOR
Intervention: PCV‐10 booster
Number of subjects: 178
Study 25636550 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed surgical exposure technique
Number of subjects: 67
Study 25636550 — intervention group
Group type: EXPERIMENTAL
Intervention: Open surgical exposure technique
Number of subjects: 67
Study 23034539 — intervention group
Group type: EXPERIMENTAL
Intervention: Active CPAP
Number of subjects: 23
Study 23034539 — intervention group
Group type: COMPARATOR
Intervention: Sham-CPAP
Number of subjects: 23
Study 23034539 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 23
Study 21905254 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain group (n = 13) - resistance training during pain induced by injections of painful hypertonic saline
Number of subjects: 27
Study 21905254 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 14) - resistance training during a nonpainful condition with injection of isotonic saline
Number of subjects: 27
Study 20074791 — intervention group
Group type: EXPERIMENTAL
Intervention: Raltegravir (400 mg twice daily; n=353)
Number of subjects: 707
Study 20074791 — intervention group
Group type: COMPARATOR
Intervention: Lopinavir-ritonavir (two 200 mg/50 mg tablets twice daily; n=354)
Number of subjects: 707
Study 17976337 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-dose vitamin D
Number of subjects: 0
Study 17976337 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium and vitamin D nutritional status improvement
Number of subjects: 0
Study 15784802 — intervention group
Group type: EXPERIMENTAL
Intervention: Single pre-exposure (group 1)
Number of subjects: 24
Study 15784802 — intervention group
Group type: EXPERIMENTAL
Intervention: Three pre-exposures (group 3)
Number of subjects: 24
Study 15784802 — intervention group
Group type: COMPARATOR
Intervention: No pre-exposure (group 0)
Number of subjects: 24
Study 15784802 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisol levels
Number of subjects: 24
Study 15784802 — intervention group
Group type: EXPERIMENTAL
Intervention: TNF-alpha levels
Number of subjects: 24
Study 15784802 — intervention group
Group type: EXPERIMENTAL
Intervention: Postrotational nausea
Number of subjects: 24
Study 12468774 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiological testings
Number of subjects: 12
Study 12468774 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronystagmography
Number of subjects: 12
Study 10496155 — intervention group
Group type: EXPERIMENTAL
Intervention: TETRAMUNE (combination vaccine of HibTITER and DTP)
Number of subjects: 93
Study 10496155 — intervention group
Group type: COMPARATOR
Intervention: DTP and HibTITER administered concurrently (separate group)
Number of subjects: 93
Study 7570885 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrarectal Quinimax® (20 mg/kg)
Number of subjects: 66
Study 7570885 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular Quinimax® (12.5 mg/kg)
Number of subjects: 66
Study 7570885 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrarectal Quinimax®
Number of subjects: 66
Study 7570885 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular Quinimax®
Number of subjects: 66
Study 2668757 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose ketoconazole (400 mg)
Number of subjects: 90
Study 2668757 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose ketoconazole (800 mg)
Number of subjects: 90
Study 2668757 — intervention group
Group type: COMPARATOR
Intervention: Placebo vaginal suppositories
Number of subjects: 90
Study 779006 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-trimoxazole (320 mg trimethoprim and 1600 mg sulphamethoxazole daily for 10 days)
Number of subjects: 45
Study 779006 — intervention group
Group type: COMPARATOR
Intervention: Nitrofurantoin (200 mg/day for 10 days)
Number of subjects: 45
Study 779006 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-trimoxazole
Number of subjects: 45
Study 779006 — intervention group
Group type: COMPARATOR
Intervention: Nitrofurantoin
Number of subjects: 45
Study 31985266 — intervention group
Group type: EXPERIMENTAL
Intervention: ALTENS four‐times weekly for 6 weeks
Number of subjects: 30
Study 31985266 — intervention group
Group type: COMPARATOR
Intervention: ALTENS two‐times weekly for 12 weeks
Number of subjects: 30
Study 30888217 — intervention group
Group type: EXPERIMENTAL
Intervention: Pycnogenol (PYC) 50 mg per day for 4 months
Number of subjects: 72
Study 30888217 — intervention group
Group type: COMPARATOR
Intervention: Escitalopram (ESC) only
Number of subjects: 72
Study 30888217 — intervention group
Group type: EXPERIMENTAL
Intervention: Pycnogenol (PYC)
Number of subjects: 72
Study 27322187 — intervention group
Group type: EXPERIMENTAL
Intervention: Early closure of temporary ileostomy (8-13 days after stoma creation)
Number of subjects: 127
Study 27322187 — intervention group
Group type: COMPARATOR
Intervention: Late closure of temporary ileostomy (>12 weeks after index surgery)
Number of subjects: 127
Study 26883526 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-assisted medication reconciliation, inpatient pharmacist counseling, low-literacy adherence aids, and individualized telephone follow-up after discharge
Number of subjects: 851
Study 26883526 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 851
Study 24248551 — intervention group
Group type: EXPERIMENTAL
Intervention: Serial plaster casting
Number of subjects: 27
Study 24248551 — intervention group
Group type: COMPARATOR
Intervention: Bebax orthoses
Number of subjects: 27
Study 23085147 — intervention group
Group type: EXPERIMENTAL
Intervention: α(+)-thalassemia homozygote (‐α/‐α)
Number of subjects: 1112
Study 23085147 — intervention group
Group type: EXPERIMENTAL
Intervention: α(+)-thalassemia heterozygote (αα/‐α)
Number of subjects: 1112
Study 23085147 — intervention group
Group type: COMPARATOR
Intervention: Wild-type children
Number of subjects: 1112
Study 19912710 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative pedobarography (IP)
Number of subjects: 100
Study 19912710 — intervention group
Group type: COMPARATOR
Intervention: No intraoperative pedobarography (no IP)
Number of subjects: 100
Study 17405834 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial combination therapy with infliximab (group 4)
Number of subjects: 508
Study 17405834 — intervention group
Group type: EXPERIMENTAL
Intervention: Step‐up combination therapy (group 2)
Number of subjects: 508
Study 17405834 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential monotherapy (group 1)
Number of subjects: 508
Study 17405834 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial combination therapy with tapered high‐dose prednisone (group 3)
Number of subjects: 508
Study 17405834 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 508
Study 15588120 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated protein C
Number of subjects: 0
Study 11271694 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral self‐management (BSM)
Number of subjects: 82
Study 11271694 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control (WLC)
Number of subjects: 82
Study 9611312 — intervention group
Group type: EXPERIMENTAL
Intervention: end-to-end anastomosis
Number of subjects: 239
Study 9611312 — intervention group
Group type: COMPARATOR
Intervention: end-to-side anastomosis
Number of subjects: 239
Study 9611312 — intervention group
Group type: COMPARATOR
Intervention: side-to-side anastomosis
Number of subjects: 239
Study 7848933 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75% bupivacaine
Number of subjects: 9
Study 7848933 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% lidocaine
Number of subjects: 9
Study 7848933 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% chloroprocaine
Number of subjects: 9
Study 7848933 — intervention group
Group type: COMPARATOR
Intervention: Unblocked dermatome (control)
Number of subjects: 9
Study 3200596 — intervention group
Group type: EXPERIMENTAL
Intervention: Pump PA
Number of subjects: 0
Study 3200596 — intervention group
Group type: EXPERIMENTAL
Intervention: Pump PB
Number of subjects: 0
Study 3200596 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 0
Study 31664960 — intervention group
Group type: EXPERIMENTAL
Intervention: Road to Mental Readiness (R2MR) program at week 2 of BMQ
Number of subjects: 2831
Study 31664960 — intervention group
Group type: COMPARATOR
Intervention: Delayed Intervention Control (R2MR at week 9 of BMQ)
Number of subjects: 2831
Study 31664960 — intervention group
Group type: EXPERIMENTAL
Intervention: Road to Mental Readiness (R2MR) program under high fidelity conditions
Number of subjects: 2831
Study 31664960 — intervention group
Group type: EXPERIMENTAL
Intervention: Road to Mental Readiness (R2MR) program under poor fidelity conditions
Number of subjects: 2831
Study 31664960 — intervention group
Group type: EXPERIMENTAL
Intervention: Road to Mental Readiness (R2MR) program
Number of subjects: 2831
Study 28630194 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g intravenous fosfomycin disodium
Number of subjects: 28
Study 28630194 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 g intravenous fosfomycin disodium
Number of subjects: 28
Study 28630194 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g oral fosfomycin tromethamine
Number of subjects: 28
Study 26525296 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based rehabilitation programme conducted once a week for four months by trained community workers supervised by a qualified physiotherapist.
Number of subjects: 0
Study 26525296 — intervention group
Group type: COMPARATOR
Intervention: Standard clinic management offered to the control group.
Number of subjects: 0
Study 23489710 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin therapy administered by insulin pen
Number of subjects: 450
Study 23489710 — intervention group
Group type: COMPARATOR
Intervention: Lower IDS satisfaction
Number of subjects: 450
Study 23489710 — intervention group
Group type: COMPARATOR
Intervention: Lower IDS social acceptability
Number of subjects: 450
Study 23489710 — intervention group
Group type: COMPARATOR
Intervention: More positive expectations of insulin therapy
Number of subjects: 450
Study 20881402 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol + Water (0.5 liter)
Number of subjects: 74
Study 20881402 — intervention group
Group type: COMPARATOR
Intervention: Placebo + Water (0.5 liter)
Number of subjects: 74
Study 19180896 — intervention group
Group type: EXPERIMENTAL
Intervention: Clobetasol propionate 0.05% spray
Number of subjects: 0
Study 19180896 — intervention group
Group type: COMPARATOR
Intervention: Calcipotriene 0.005% betamethasone dipropionate 0.064% ointment
Number of subjects: 0
Study 18322602 — intervention group
Group type: EXPERIMENTAL
Intervention: Fufang Biejia Ruangan tablet (FBRt)
Number of subjects: 420
Study 18322602 — intervention group
Group type: COMPARATOR
Intervention: He Luo Shu Gan capsule (Control)
Number of subjects: 420
Study 15670971 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct venography technique
Number of subjects: 83
Study 15670971 — intervention group
Group type: COMPARATOR
Intervention: Occlusive venography technique
Number of subjects: 83
Study 12136475 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunodepressive therapy
Number of subjects: 2000
Study 12136475 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous pulse therapy with cyclophosphamide
Number of subjects: 2000
Study 12136475 — intervention group
Group type: COMPARATOR
Intervention: Oral cyclophosphamide
Number of subjects: 2000
Study 12136475 — intervention group
Group type: COMPARATOR
Intervention: Intravenous pulse therapy
Number of subjects: 2000
Study 12136475 — intervention group
Group type: COMPARATOR
Intervention: IgA nephropathy (IgA-N)
Number of subjects: 2000
Study 10417589 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquaphor mixed with vitamin E (B)
Number of subjects: 15
Study 10417589 — intervention group
Group type: COMPARATOR
Intervention: Aquaphor (A)
Number of subjects: 15
Study 7573298 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mg/day estradiol patch
Number of subjects: 603
Study 7573298 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05 mg/day estradiol patch
Number of subjects: 603
Study 7573298 — intervention group
Group type: COMPARATOR
Intervention: Climara patch
Number of subjects: 603
Study 7573298 — intervention group
Group type: COMPARATOR
Intervention: Conjugated equine estrogens (Premarin)
Number of subjects: 603
Study 7573298 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 603
Study 2201730 — intervention group
Group type: EXPERIMENTAL
Intervention: Zopiclone (7.5 mg)
Number of subjects: 10
Study 2201730 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam (0.25 mg)
Number of subjects: 10
Study 2201730 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 7337837 — intervention group
Group type: EXPERIMENTAL
Intervention: Mantle irradiation or inverted Y radiotherapy (group 7701 S)
Number of subjects: 79
Study 7337837 — intervention group
Group type: COMPARATOR
Intervention: Focal irradiation only (group 7701 F)
Number of subjects: 79
Study 31464757 — intervention group
Group type: EXPERIMENTAL
Intervention: Gaming balance board intervention for 12 weeks
Number of subjects: 56
Study 31464757 — intervention group
Group type: COMPARATOR
Intervention: Control group using computer mouse in standing position
Number of subjects: 56
Study 30991441 — intervention group
Group type: EXPERIMENTAL
Intervention: Betamethasone
Number of subjects: 2331
Study 30991441 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2331
Study 27977819 — intervention group
Group type: EXPERIMENTAL
Intervention: Feather-edge preparation
Number of subjects: 58
Study 27977819 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep chamfer preparation
Number of subjects: 58
Study 25853745 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh red cells (stored for less than 8 days)
Number of subjects: 1211
Study 25853745 — intervention group
Group type: COMPARATOR
Intervention: Standard-issue red cells (the oldest compatible units available)
Number of subjects: 1211
Study 25853745 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh red cells
Number of subjects: 1211
Study 25853745 — intervention group
Group type: COMPARATOR
Intervention: Standard-issue red cells
Number of subjects: 1211
Study 23548118 — intervention group
Group type: EXPERIMENTAL
Intervention: Paeoniflorin (PAE) + cervus and cucumis polypeptide injection (CCPI)
Number of subjects: 0
Study 23548118 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (MTX) + leflunomide (LEF)
Number of subjects: 0
Study 23548118 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) + leflunomide (LEF) + CCPI
Number of subjects: 0
Study 23548118 — intervention group
Group type: EXPERIMENTAL
Intervention: CCPI (as an add-on to DMARDs)
Number of subjects: 0
Study 22462231 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood-increasing decoction and blood-generating powder for 1-3 months
Number of subjects: 200
Study 22462231 — intervention group
Group type: COMPARATOR
Intervention: Amino-polypeptide as a basic treatment
Number of subjects: 200
Study 19624787 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolterodine ER (4 mg)
Number of subjects: 4163
Study 19624787 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4163
Study 16625009 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 215
Study 16625009 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 215
Study 15272149 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-occlusive reactive hyperemia (PORH) test
Number of subjects: 0
Study 15272149 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 0
Study 15272149 — intervention group
Group type: EXPERIMENTAL
Intervention: PVD indicators
Number of subjects: 0
Study 11701786 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized trials involving fracture care
Number of subjects: 19942
Study 9046249 — intervention group
Group type: EXPERIMENTAL
Intervention: Vancomycin 20 micrograms/mL and Gentamicin 8 micrograms/mL in the irrigating fluid
Number of subjects: 120
Study 9046249 — intervention group
Group type: COMPARATOR
Intervention: Placebo (only irrigating fluid)
Number of subjects: 120
Study 7959572 — intervention group
Group type: EXPERIMENTAL
Intervention: OK-432 (administered pre-operatively via hepatic artery)
Number of subjects: 10
Study 7959572 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment with OK-432)
Number of subjects: 10
Study 3146369 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 44
Study 3146369 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 30117638 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh activated Miswak
Number of subjects: 24
Study 30117638 — intervention group
Group type: COMPARATOR
Intervention: Inactivated Miswak
Number of subjects: 24
Study 26247014 — intervention group
Group type: EXPERIMENTAL
Intervention: COH‐IUI
Number of subjects: 238
Study 26247014 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 238
Study 23595590 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical zinc oxide treatment
Number of subjects: 42
Study 23595590 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral zinc, copper, and selenium combined
Number of subjects: 42
Study 23595590 — intervention group
Group type: COMPARATOR
Intervention: Elective surgery
Number of subjects: 42
Study 23595590 — intervention group
Group type: COMPARATOR
Intervention: Patients with abscesses
Number of subjects: 42
Study 23595590 — intervention group
Group type: COMPARATOR
Intervention: Wound edges
Number of subjects: 42
Study 23595590 — intervention group
Group type: COMPARATOR
Intervention: Wound edge
Number of subjects: 42
Study 21709199 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium plus vitamin D supplementation (1,000 mg of elemental calcium plus 400 IU of vitamin D3 daily)
Number of subjects: 36282
Study 21709199 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36282
Study 19535421 — intervention group
Group type: EXPERIMENTAL
Intervention: Stearate-enriched plant sterol esters (3 g/d, 1 g three times per day with meals)
Number of subjects: 32
Study 19535421 — intervention group
Group type: EXPERIMENTAL
Intervention: Stearate-enriched plant sterol esters
Number of subjects: 32
Study 19535421 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 17166443 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive intervention including semi-recumbent position, mosapride citrate, and endotracheal tube for continuous subglottic secretions drainage
Number of subjects: 86
Study 17166443 — intervention group
Group type: COMPARATOR
Intervention: Standard endotracheal tube (control group)
Number of subjects: 86